Innoveren Scientific Inc. (IVRN)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Oct 7, 2026
Innoveren Scientific Market Cap
Innoveren Scientific has a market cap or net worth of $2.4 thousand as of October 16, 2026. It is the 52,200th most valuable company in the world and the 8,241st biggest in the United States. Its market cap has increased by 49.94% in one year.
Market Cap
2.40K
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,241 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since January 9, 2019, Innoveren Scientific's market cap has decreased from 8.65M to 2.40K, a decrease of -99.97%. That is a compound annual growth rate of -65.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 3.20K | -42.86% |
| Dec 24, 2025 | 5.61K | 133.39% |
| Dec 23, 2024 | 2.40K | -97.89% |
| Dec 29, 2023 | 113.99K | -92.96% |
| Dec 29, 2022 | 1.62M | -82.58% |
| Dec 31, 2021 | 9.30M | 348.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anthera Pharmaceuticals | 3.53K |
| Affimed | 3.28K |
| Rebus Holdings | 3.21K |
| Hemagen Diagnostics | 3.10K |
| Comera Life Sciences Holdings | 3.07K |
| OncoVista Innovative Therapies | 2.36K |
| Lipella Pharmaceuticals | 2.31K |
| Suvanza Pharma, LLC | 2.24K |